Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 20 Nov 2026, 11:01 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+395%
- Median
- +27.7%
- Combined market value
- SAR 14.02T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | SAR 18.7B | SAR 53.35 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | SAR 34.8B | SAR 366.30 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | SAR 24.8B | SAR 366.07 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | SAR 19.7B | SAR 466.70 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | SAR 15.1B | SAR 110.61 | 1.24% up | 168% up | ||
| 6 | TG TherapeuticsTGTX · Health Care | +117% | SAR 36.8B | SAR 243.42 | 1.88% down | 117% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +108% | SAR 17.9B | SAR 318.27 | 1.01% up | 108% up | ||
| 8 | ViatrisVTRS · Health Care | +99.0% | SAR 85.5B | SAR 74.59 | 1.97% down | 99% up | ||
| 9 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | SAR 28B | SAR 80.25 | 2.24% down | 90% up | ||
| 10 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | SAR 32.6B | SAR 1,166.47 | 1.87% up | 86% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | SAR 16.9B | SAR 154.47 | 0.48% down | 86% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +78.9% | SAR 146.1B | SAR 254.08 | 1.38% down | 79% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | SAR 30.4B | SAR 465.31 | 2.47% down | 51% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | SAR 21.5B | SAR 1,076.57 | 3.94% down | 50% up | ||
| 15 | Merck & CoMRK · Health Care | +45.1% | SAR 1.23T | SAR 498.29 | 3.61% down | 45% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | +44.7% | SAR 17.4B | SAR 181.22 | 3.86% down | 45% up | ||
| 17 | Belite BioBLTE · Health Care | +43.1% | SAR 23B | SAR 566.61 | 3.33% down | 43% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +34.3% | SAR 2.41T | SAR 1,002.28 | 2.04% down | 34% up | ||
| 19 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | SAR 23.4B | SAR 358.34 | 3.27% up | 34% up | ||
| 20 | Eli LillyLLY · Health Care | +32.5% | SAR 4.52T | SAR 5,069.27 | 2.29% down | 33% up | ||
| 21 | Bristol-Myers SquibbBMY · Health Care | +29.6% | SAR 447.4B | SAR 218.89 | 2.05% down | 30% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | SAR 358.4B | SAR 3,464.28 | 2.35% down | 28% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | SAR 495.3B | SAR 1,953.46 | 2.94% down | 27% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | +25.7% | SAR 49.3B | SAR 98.64 | 1.54% down | 26% up | ||
| 25 | AbbVieABBV · Health Care | +24.7% | SAR 1.88T | SAR 1,063.81 | 0.86% down | 25% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +21.6% | SAR 89.3B | SAR 2,097.69 | 3.16% down | 22% up | ||
| 27 | BridgeBio PharmaBBIO · Health Care | +20.7% | SAR 57.1B | SAR 293.32 | 0.22% up | 21% up | ||
| 28 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | SAR 30.4B | SAR 438.22 | 1.88% down | 18% up | ||
| 29 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | SAR 44.6B | SAR 230.44 | 0.02% down | 17% up | ||
| 30 | PfizerPFE · Health Care | +15.0% | SAR 589B | SAR 103.33 | 1.85% down | 15% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | SAR 23.2B | SAR 163.77 | 1.25% up | 13% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -6.50% | SAR 26.8B | SAR 509.06 | 1.25% up | 6% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -9.67% | SAR 26.7B | SAR 243.80 | 4.15% down | 10% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -15.7% | SAR 675B | SAR 389.71 | 0.58% down | 16% down | ||
| 35 | CytokineticsCYTK · Health Care | -19.2% | SAR 26.9B | SAR 193.07 | 0.27% up | 19% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -19.9% | SAR 18.1B | SAR 104.08 | 0.25% down | 20% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -21.2% | SAR 18.3B | SAR 218.83 | 3.16% down | 21% down | ||
| 38 | ZoetisZTS · Health Care | -26.2% | SAR 123.2B | SAR 303.12 | 5.59% down | 26% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | SAR 34.6B | SAR 1,488.53 | 0.34% down | 27% down | ||
| 40 | Summit TherapeuticsSMMT · Health Care | -36.2% | SAR 31.7B | SAR 39.66 | 0.67% up | 36% down | ||
| 41 | InsmedINSM · Health Care | -40.0% | SAR 118.9B | SAR 542.00 | 20.58% up | 40% down | ||
| 42 | Legend BiotechLEGN · Health Care | -41.0% | SAR 11.7B | SAR 60.41 | 0.92% down | 41% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | SAR 17B | SAR 102.13 | 0.62% down | 63% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | SAR 74.3B | SAR 554.61 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7519 SAR).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 11:01 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of SAR 14.02T as of 20 Nov 2026, 11:01 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.